Trial title not recorded
Bladder Cancer
Enrolment: 120 · Results not recorded
Loading the evidence…
Drug · DNA inhibitor (action_type INHIBITOR; direct interaction, disease efficacy true)
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Bladder Cancer
Enrolment: 120 · Results not recorded
Oropharyngeal Cancer
Enrolment: 280 · Results not recorded
Stomach Cancer
Enrolment: 528 · Results not recorded
Anus Neoplasms · Carcinoma, Squamous Cell
Enrolment: 314 · Results not recorded
Keratoconus · Post LASIK Keratectasia
Enrolment: 66 · Results not recorded
Cancer, Appendiceal · ColoRectal Cancer
Enrolment: 100 · Results not recorded
Stomach Neoplasms · Colorectal Neoplasms · Neoplasm Metastasis · Mesothelioma
Enrolment: 60 · Results not recorded
Recurrence Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma
Enrolment: 60 · Results not recorded
Hyperopia
Enrolment: 36 · Results not recorded
Neovascular Glaucoma · Intraocular Pressure
Enrolment: 5 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Electrocautery myringotomy of the tympanic membrane (acute perforation)
Complete healing was significantly less frequent in the mitomycin C group than the saline group at days 7 and 14 (P<0.05). Growth factor expression was largely unchanged except for higher transforming growth factor beta1 in macrophages at day 3 in the mitomycin C group (P=0.001).
Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.